IBM leads on AI healthcare patent quantity while Philips is ahead on quality, data analysis shows
Life sciences companies are being left to play catch-up as tech companies build robust portfolios in anticipation of a market whose time is about to come
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.